Differential distribution of diacylglycerol lipase-alpha and N-acylphosphatidylethanolamine-specific phospholipase d immunoreactivity in the superficial spinal dorsal horn of rats

GLIA

Volumn 60, Issue 9, 2012, Pages 1316-1329

  Hegyi, Zoltán ^a   Holló, Krisztina ^a   Kis, Gréta ^a   Mackie, Ken ^b   Antal, Miklós ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b INDIANA UNIVERSITY   (United States)

Author keywords

DGL ; Glial cells; Interneurons; NAPE PLD; Nociceptive primary afferents

Indexed keywords

CD11B ANTIGEN; DIACYLGLYCEROL LIPASE ALPHA; LIPOPROTEIN LIPASE; N ACYLPHOSPHATIDYLETHANOLAMINE SPEFIC PHOSPHOPLIPASE D; PHOSPHATIDYLETHANOLAMINE; PHOSPHOLIPASE D; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DENDRITE; ELECTRON MICROSCOPY; ENZYME SYNTHESIS; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MICROSCOPY; NERVE ENDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; SPINAL CORD DORSAL HORN; SYNAPSE;

ANIMALS; ASTROCYTES; DENDRITES; LIPOPROTEIN LIPASE; MICROGLIA; NEURONS; PHOSPHOLIPASE D; RATS; RATS, INBRED WKY; SPINAL CORD; SYNAPSES;

EID: 84864002386     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22351     Document Type: Article

References (114)

1. Ahluwalia J, Urban L, Bevan S, Nagy I. 2003. Anandamide regulates neuropeptide release from capsaicin-sensitive primary sensory neurons by activating both the cannabinoid 1 receptor and the vanilloid receptor 1 in vitro. Eur J Neurosci 17: 2611-2618.
2. Araque A, Carmignoto G, Haydon PG. 2001. Dynamic signaling between neurons and glia. Annu Rev Physiol 63: 795-813.
3. Beltramo M, Piomelli D. 2000. Carrier-mediated transport and enzymatic hydrolysis of the endogenous cannabinoid 2-arachidonylglycerol. Neuroreport 11: 1231-1235.
4. Bisogno T, Howell F, Williams G, Minassi A, Cascio MG, Ligresti A, Matias I, Schiano-Moriello A, Paul P, Williams EJ, Gagadharan U, Hobbs C, Di Marzo V, Doherty P. 2003. Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain. J Cell Biol 163: 463-468.
5. Bisogno T, Melck D, De Petrocellis L, Di Marzo V. 1999. Phosphatidic acid as the biosynthetic precursor of the endocannabinoid 2-arachidonoylglycerol in intact mouse neuroblastoma cells stimulated with ionomycin. J Neurochem 72: 2113-2119.
6. Bisogno T, Sepe N, Melck D, Maurelli S, De Petrocellis L, Di Marzo V. 1997. Biosynthesis, release and degradation of the novel endogenous cannabimimetic metabolite 2-arachidonoylglycerol in mouse neuroblastoma cells. Biochem J 322: 671-677.
7. Cabral GA, Marciano-Cabral F. 2005. Cannabinoid receptors in microglia of the central nervous system: Immune functional relevance. J Leukoc Biol 78: 1192-1197.
8. Cao H, Zhang YQ. 2008. Spinal glia activation contributes to pathological pain states. Neurosci Behav Rev 32: 972-983.
9. 2 receptor-dependent mechanism. Mol Pharmacol 65: 999-1007.
10. Chapman V. 1999. The cannabinoid CB1 receptor antagonist, SR141716A, selectively facilitates nociceptive responses of dorsal horn neurons in the rat. Br J Pharmacol 127: 1765-1767.
11. Chevaleyre V, Takahashi KA, Castillo PE. 2006. Endocannabinoid-mediated synaptic plasticity in the CNS. Annu Rev Neurosci 29: 37-76.
12. Cristino L, Starowicz K, De Petrocellis L, Morishita J, Ueda N, Guglielmotti V, Di Marzo V. 2008. Immunohistochemical localization of anabolic and catabolic enzymes for anadamide and other putative endovanilloids in the hippocampus and cerebellar cortex of the mouse brain. Neuroscience 151: 955-968.
13. Devane WA, Hanus L, Breuer A, Pertwee RG., Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A, Mechoulam R. 1992. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258: 1946-1949.
14. Di Marzo V. 2008. Targeting the endocannabinoid system: To enhance or reduce? Nat Rev Drug Discov 7: 438-455.
15. Di Marzo V, Fontana A, Cadas H, Schinelli S, Cimino G, Schwartz JC, Piomelli D. 1994. Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 372: 689-691.
16. Dinh TP, Carpenter D, Leslie FM, Freund TF, Katona I, Sensi SL, Kathuria S, Piomelli D. 2002. Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc Natl Acad Sci USA 99: 10819-10824.
17. Drew LJ, Harris J, Millns PJ, Kendall DA, Chapman V. 2000. Activation of spinal cannabinoid 1 receptors inhibits C-fibre driven hyperexcitable neuronal responses and increases [35S]GTPgammaS binding in the dorsal horn of the spinal cord of noninflamed rats. Eur J Neurosci 12: 2079-2086.
18. Egertova M, Simon GM, Cravatt BF, Elphick MR. 2008. Localization of N-acyl phosphatidylethanolamine phospholipase d (NAPE-PLD) expression in mouse brain: A new perspective on N-acylethanolamines as neural signaling molecules. J Comp Neurol 506: 604-615.
19. Eriksson NP, Persson JK, Svensson M, Arvidsson J, Molander C, Aldskogius H. 1993. A quantitative analysis of the microglial cell reaction in central primary sensory projection territories following peripheral nerve injury in the adult rat. Exp Brain Res 96: 9-27.
20. Farquhar-Smith WP, Egertová M, Bradbury EJ, McMahon SB, Rice ASC, Elphick MR. 2000. Cannabinoid CB1 receptor expression in rat spinal cord. Mol Cell Neurosci 15: 510-521.
21. Feldblum S, Dumoulin A, Anoal M, Sandillon F, Privat A. 1995. Comparative distribution of GAD65 and GAD67 mRNAs and proteins in the rat spinal cord supports a differential regulation of these two glutamate decarboxylases in vivo. J Neurosci Res 42: 742-757.
22. Gao Y, Vasilyev DV, Goncalves MB, Howell FV, Hobbs C, Reisenberg M, Shen R, Zhang MY, Strassle BW, Lu P, Mark L, Piesla MJ, Deng K, Kouranova, EV, Ring RH, Whiteside GT, Bates B, Walsh FS, Williams G, Pangalos MN, Samad TA, Doherty P. 2010. Loss of retrograde endocannabinoid signaling and reduced adult neurogenesis in diacylglycerol lipase knock-out mice. J Neurosci 30: 2017-2024.
23. Garrison CJ, Dougherty PM, Kajander KC, Carlton SM. 1991. Staining of glial fibrillary acidic protein (GFAP) in lumbar spinal cord increases following a sciatic nerve constriction injury. Brain Res 565: 1-7.
24. Graeber MB. 2010. Changing face of microglia. Science 330: 783-788.
25. Guo A, Vulchanova L, Wang J, Li X, Elde R. 1999. Immunocytochemical localization of the vanilloid receptor 1 (VR1): Relationship to neuropeptides, the P2X3 purinoceptor abd IB4 binding sites. Eur J Neurosci 11: 946-958.
26. Haydon PG, Carmingnoto G. 2006. Astrocyte control of synaptic transmission and neurovascular coupling. Physiol Rev 86: 1009-1031.
27. Hegyi Z, Kis G, Holló K, Leden C, Antal M. 2009. Neuronal and glial localization of the cannabinoid-1 receptor in the superficial spinal dorsal horn of the rodent spinal cord. Eur J Neurosci 30: 251-262.
28. Herkenham M, Lynn AB, Johnson MR, Melvin LS, de Costa BR, Rice KC. 1991. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J Neurosci 11: 563-583.
29. Herzberg U, Eliav E, Bennett GJ, Kopin IJ. 1997. The analgesic effects of R(+)-WIN 55, 212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain. Neurosci Lett 221: 157-160.
30. Hohmann AG, Martin WJ, Tsou K, Walker JM. 1995. Inhibition of noxious stimulus-evoked activity of spinal cord dorsal horn neurons by the cannabinoid WIN55, 212-2. Life Sci 56: 2111-2118.
31. Hohmann AG, Tsou K, Walker JM. 1998. Cannabinoid modulation of wide dynamic range neurons in the lumbar dorsal horn of the rat by spinally administered WIN55, 212-2. Neurosci Lett 257: 119-122.
32. Hohmann AG, Tsou K, Walker JM. 1999. Cannabinoid suppression of noxious heat-evoked activity in wide dynamic range neurons in the lumbar dorsal horn of the rat. J Neurophysiol 81: 575-583.
33. Kano M, Ohno-Shosaku T, Hashimotodani Y, Uchigashima M, Watanabe M. 2009. Endocannabinoid-mediated control of synaptic transmission. Physiol Rev 89: 309-380.
34. Katona I, Freund TF. 2008. Endocannabinoid signaling as a synaptic circuit breaker in neurological disease. Nat Med 14: 923-930.
35. Katona I, Sperlágh B, Sík A, Kofalvi A, Vizi ES, Mackie K, Freund TF. 1999. Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J Neurosci 19: 4544-4558.
36. Katona I, Urbán G.M, Wallace M, Ledent C, Jung KM, Piomelli D, Mackie K, Freund TF. 2006. Molecular composition of the endocannabinoid system at glutamatergic synapses. J Neurosci 26: 5628-5637.
37. Kawamura Y, Fukaya M, Maejima T, Yoshida T, Miura E, Watanabe M, Ohno-Shosaku T, Kano M. 2006. The CB1 cannabinoid receptor is the major cannabinoid receptor at excitatory presynaptic sites in the hippocampus and cerebellum. J Neurosci 26: 2991-3001.
38. Kelly S, Chapman V. 2001. Selective cannabinoid CB1 receptor activation inhibits spinal nociceptive transmission in vivo. J Neurophysiol 86: 3061-3064.
39. Kim J, Alger BE. 2004. Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus. Nat Neurosci 7: 697-698.
40. Kim J, Alger BE. 2010. Reduction in endocannabinoid tone is a homeostatic mechanism for specific inhibitory synapses. Nature Neurosci 13: 592-600.
41. Kreitzer ACRegehr WG. 2001. Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells. Neuron 29: 717-727.
42. Kreitzer AC, Carter AG, Regehr WG. 2002. Inhibition of interneuron firing extends the spread of endocannabinoid signaling in the cerebellum. Neuron 34: 787-796.
43. Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
44. La Rana G, Russo R, Campolongo P, Bortolato M, Mangieri RA, Cuomo V, Iacono A, Raso GM, Meli R, Piomelli D, Calignano A. 2006 Modulation of neuropathic and inflammatory pain by the endocannabinoid transport inhibitor AM404 [N-(4-hydroxyphenyl)-eicosa-5, 8, 11, 14-tetraenamide]. J Pharmacol Exp Ther 317: 1365-1371.
45. Leung D, Saghatelian A, Simon GM, Cravatt BF. 2006. Inactivation of N-acyl phosphatidylethanolamine phospholipase D reveals multiple mechanisms for the biosynthesis of endocannabinoids. Biochemistry 45: 4720-4726.
46. Li JL, Fujimaya F, Kaneko T, Mizuno N. 2003. Expression of vesicular glutamate transporters, VGluT1 and VGluT2, in axon terminals of nociceptive primary afferent fibers in the superficial layers of the medullary and spinal dorsal horns of the rat. J Comp Neurol 457: 236-249.
47. Liu J, Wang L, Harvey-White J, Osei-Hyiaman D, Razdan R, Gong Q, Chan AC, Zhou Z, Huang BX, Kim HY, Kunos G. 2006. A biosynthetic pathway for anadamide. Proc Natl Acad Sci USA 103: 13345-13350.
48. Liu J, Wang L, Harvey-White J, Huang BX, Kim HY, Luquet S, Palmiter RD, Krystal G, Rai R, Mahadevan A, Razdan RK, Kunos G. 2008. Multiple pathways involved in the biosynthesis of anandamide. Neuropharmacol 54: 1-7
49. Liu CH, Heynen AJ, Shuler MG, Bear MF. 2008. Cannabinoid receptor blockade reveals parallel plasticity mechanisms in different layers of mouse visual cortex. Neuron 58: 340-345.
50. Ludányi A, Hu SSJ, Yamazaki M, Tanimura A, Piomelli D, Watanabe M, Kano M, Sakimura K, Maglóczky Z, Mackie K, Freund TF, Katona I. 2011. Complementary synaptic distribution of enzymes responsible for synthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in the human hippocampus. Neuroscience 174: 50-63.
51. Mackie M, Hughes DI, Maxwell DJ, Tillakaratne NJK, Todd AJ. 2003. Distribution and co-localization of glutamate decarboxylase isoforms in the rat spinal cord. Neuroscience 119: 461-472.
52. Marinelli S, Pacioni S, Bisogno T, Di Marzo V, Prince DA, Hugunard JR, Bacci A. 2008. The endocannabinoid 2-arachidonoylglycerol is responsible for the slow self-inhibition in neocortical interneurons. J Neurosci 28: 13532-13541.
53. Marsicano G, Goodenough S, Monory K, Hermann H, Eder M, Cannich A, Azad SC, Grazia Casio M, Ortega Gutiérrez S, Van der Stelt M, López-Rodriguez ML, Casanova E, Schütz G, Zieglgänsberger W, Di Marzo V, Behl C, Lutz B. 2003. CB1 cannabinoid receptors and on-demand defense against excitotoxicity. Science 302: 84-88.
54. Martin DL, Liu H, Martin SB, Wu SJ. 2000. Structural features and regulatory properties of the brain glutamate decarboxylases. Neurochem Int 37: 111-119.
55. Matsuda LA, Bonner TI, Lolait SJ. 1993. Localization of cannabinoid receptor mRNA in rat brain. J Comp Neurol 327: 535-550.
56. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI. 1990. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346: 561-564.
57. McClung JR, Castro AJ. 1978. Rexed's laminar scheme as it applies to the rat cervical spinal cord. Exp Neurol 58: 145-148.
58. McNeill DL, Chung K, Hulsebosch CE, Bolender RP, Coggeshall RE. 1988. Numbers of synapses in laminae I-IV of the rat dorsal horn. J Comp Neurol 278: 453-460.
59. Mechoulam R, Ben-Shabat S, Hanus L, Ligunsky M, Kaminski NE, Schatz AR, Gopher A, Almog S, Martin BR, Compton DR. 1995. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol 50: 83-90.
60. Molander C, Hongpaisan J, Evensson M, Aldskogius H. 1997. Glial cell reactions in the spinal cord after sensory nerve stimulation are associated with axonal injury. Brain Res 747: 122-129.
61. Molander C, Xu Q, Grant G. 1984. The cytoarchitectonic organization of the spinal cord in the rat. I. The lower thoracic and lumbosacral cord. J Comp Neurol 230: 133-141.
62. Morishita W, Marie H, Malenka RC. 2005. Distinct triggering and expression mechanisms underlie LTD of AMPA and NMDA synaptic responses. Nat Neurosci 8: 1043-1050.
63. Morisset V, Urban L. 2001. Cannabinoid-induced presynaptic inhibition of glutamatergic EPSCs in substantia gelatinosa neurons of the rat spinal cord. J Neurophysiol 86: 40-48.
64. Nagy B, Fedonidis C, Photiou A, Wahba J, Paule CC, Ma D, Buluwela L, Nagy I. 2009. Capsaicin-sensitive primary sensory neurons in the mouse express N-acyl phosphatidylethanolamine phospholipase D. Neuroscience 161: 572-577.
65. Nasu F. 1999. Analysis of calcitonin gene-related peptide (CGRP)-containing nerve fibres in the rat spinal cord using light and electron microscopy. J Electron Microsc 48: 267-275.
66. Navarrate M, Araque A. 2008. Endocannabinoids mediate neuron-astrocyte communication. Neuron 57: 883-893.
67. Nedergaard M, Ransom B, Goldman SA. 2003. New roles for astrocytes: Redefining the functional architecture of the brain. Trends Neurosci 26: 523-530.
68. Nyilas R, Dudok B, Urbán GM, Mackie K, Watanabe M, Cravatt BF, Freund TF, Katona I. 2008. Enzymatic machinery for endocannabinoid biosynthesis associated with calcium stores in glutamatergic axon terminals. J Neurosci 28: 1058-1063.
69. Nyilas R, Gregg LC, Mackie K, Watanabe M, Zimmer A, Hohmann AG, Katona I. 2009. Molecular architecture of endocannabinoid signaling at nociceptive synapses mediating analgesia. Eur J Neurosci 29: 1964-1978.
70. Ohno-Shosaku T, Maejima T, Kano M. 2001. Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals. Neuron 29: 729-738.
71. Okamoto Y, Morishita J, Tsuboi K, Tonai T, Ueda N. 2004. Molecular characterization of a phospholipase D generating anandamide and its congeners. J Biol Chem 279: 5298-5305.
72. Okamoto Y, Wang J, Morishita J, Ueda N. 2007. Biosynthetic pathways of the endocannabinoid anandamide. Chem Biodivers 4: 1842-1857.
73. Oliveira ALR, Hydling F, Olsson E, Shi T, Edwards RH, Fujiyama F, Kaneko T, Hökfelt T, Cullheim S, Meister B. 2003. Cellular localization of three vesicular glutamate transporter mRNAs and proteins in rat spinal cord and dorsal root ganglia. Synapse 50: 117-129.
74. Pacher P, Batkai S, Kunos G. 2006. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev 58: 389-462.
75. Pernia-Andrade AJ, Kato A, Witschi R, Nyilas R, Katona I, Freund TF, Watanabe M, Filitz J, Koppert W, Schüttler J, Ji G, Neugebauer V, Marsicano G, Lutz B, Vanegas H, Zeilhofer HU. 2009. Spinal endocannabinoids and CB1 receptors mediate C-fiber-induced heterosynaptic pain sensitization. Science 325: 760-764.
76. Piomelli D. 2003. The molecular logic of endocannabinoid signalling. Nat Rev Neurosci 4: 873-884.
77. Ribeiro da Silva A, De Korninck Y. 2009. Morphological and neurochemical organization of the spinal dorsal horn. In: Basbaum AI, Bushnell MC, editors Science of pain. Oxford: Elsevier. pp 279-310.
78. Rodriquez JJ, Mackie K, Pickel VM. 2001. Ultrastructural localization of the CB1 cannabinoid receptor in mu-opioid receptor patches of the rat caudate putamen nucleus. J Neurosci 21: 823-833.
79. Runyan SA, Roy RR, Zhong H, Phelps PE. 2007. L1 cell adhesion molecule is not required for small-diameter primary afferent sprouting after deafferentation. Neuroscience 150: 959-969.
80. Salio C, Doly S, Fischer J, Franzoni, MF, Conrath M. 2002. Neuronal and astrocytic localization of the cannabinoid receptor-1 in the dorsal horn of the rat spinal cord. Neurosci Lett 329: 13-16.
81. Schmid HHO, Schmid PC, Berdyshev EV. 2002. Cell signaling by endocannabinoids and their congeners: Questions of selectivity and other challenges. Chem Phys Lipids 121: 111-134.
82. Scholz J, Woolf CJ. 2007. the neuropathic pain triad: neurons, immune cells and glia. Nat Neurosci 11: 1361-1368.
83. Simon GM, Cravatt BF. 2006. Endocannabinoid biosynthesis proceeding through glycerophospho-N-acyl ethanolamine and a role for alpha/beta-hydrolase 4 in this pathway. J Biol Chem 281: 26465-26472.
84. Simon GM, Cravatt BF. 2008. Anandamide biosynthesis catalyzed by the phosphodiesterase GDE1 and detection of glycerophospho-N-acyl ethanolamine precursors in mouse brain. J Biol Chem 283: 9341-9349.
85. Soghomonian JJ, Martin DL. 1988. Two isoforms of glutamate decarboxylase: why? Trends Pharmacol Sci 19: 500-505.
86. Stella N, Piomelli D. 2001. Receptor-dependent formation of endogenous cannabinoids in cortical neurons. Eur J Pharmacol 425: 189-196.
87. Stella N, Schweitzer P, Piomelli D. 1997. A second endogenous cannabinoid that modulates long-term potentiation. Nature 388: 773-778.
88. Streit WJ. 1990. An improved staining method for rat microglial cells using the lectin from Griffonia simplicifolia (GSA I-B4). J Histochem Cytochem 38: 1683-1686.
89. Suarez J, Bermúdez-Silva FJ, Mackie K, Ledent C, Zimmer A, Cravatt BF, De Fonseca FR. 2008. Immunohistochemical description of the endogenous cannabinoid system in the rat cerebellum and functionally related nuclei. J Comp Neurol 509: 400-421.
90. Sugiura T, Kobayashi Y, Oka S, Waku K. 2002. Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance. Prostaglandins Leukot Essent Fatty Acids 66: 173-092.
91. Sugiura T, Kondo S, Sukagawa A, Nakane S, Shinoda A, Itoh K, Yamashita A, Waku K. 1995. 2-Arachidonoylglycerol: A possible endogenous cannabinoid receptor ligand in brain. Biochem Biophys Res Commun 215: 89-97.
92. Sugiura T, Kondo S, Sukagawa A, Tonegawa T, Nakane S, Yamashita A, Waku K. 1996. N-arachidonoylethanolamine (anandamide), an endogenous cannabinoid receptor ligand, and related lipid molecules in the nervous tissues. J Lipid Mediat Cell Signal 14: 51-56.
93. Suter MR, Wen YR, Decosterd I, Ji RR. 2007. Do glial cells control pain? Neuron Glia Biol 3: 255-268.
94. Tanimura A, Yamazaki M, Hashimotodani Y, Ushigashima M, Kawata S, Abe M, Kita Y, Hashimoto K, Shimizu T, Watanabe M, Sakimura K, Kano M. 2010. The endocannabinoid 2-arachidonoylglycerol produced by diacylglycerol lipase α mediates retrograde suppression of synaptic transmission. Neuron 65: 320-327.
95. Todd AJ, Hughes DI, Polgár E, Nagy G.G., Mackie M, Ottersen OP, Maxwell DJ. 2003. The expression of vesicular glutamate transporters VGLUT1 and VGLUT2 in neurochemically defined axonal populations in the rat spinal cord with emphasis on the dorsal horn. Eur J Neurosci 17: 13-27.
96. Tran TS, Alijani A, Phelps PE. 2003. Unique developmental patterns of GABAergic neurons in rat spinal cord. J Comp Neurol 456: 112-126.
97. Traub RJ, Solodkin A, Ruda MA. 1989. Calcitonin gene-related peptide immunoreactivity in the cat lumbosacral spinal cord and the effects of multiple dorsal rhizotomies. J Comp Neurol 287: 225-237.
98. Tsou K, Brown S, Sanudo-Pena MC, Mackie K, Walker JM. 1998. Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 83: 393-411.
99. 2+ influx via TRPV1 channels. EMBO J 24: 3026-3037.
100. Villeda SA, Akopians AL, Babayan AH, Basbaum AI, Phelps PE. 2006. Absence of reelin results in altered nociception and aberrant neuronal positioning in the dorsal spinal cord. Neuroscience 139: 1385-1396.
101. Volterra A, Bezzi P. 2002. The tripartite synapse: Glia. In: Volterra A, Magistretti PJ, Haydon PG editors. Synaptic transmission. New York: Oxford UP. pp 164-168.
102. Walter L, Stella L. 2003. Endothelin-1 increases 2-arachidonyl glycerol (2-AG) production in astrocytes. Glia 44: 85-90.
103. Walter L, Stella N. 2004. Cannabinoids and neuroinflammation. Br J Pharmacol 141: 775-785.
104. Walter L, Dinh T, Stella N. 2004. ATP induces a rapid and pronounced increase in 2-arachidonoylglycerol production by astrocytes, a response limited by monoacylglycerol lipase. J Neurosci 24: 8068-8074.
105. Walter L, Franklin A, Witting A, Möller T, Stella N. 2002. Astrocytes in culture produce anadamide and other acylethanolamides. J Biol Chem 277: 20869-20876.
106. Walter L, Franklin A, Witting A, Wade C, Xie Y, Kunos G, Mackie K, Stella N. 2003. Non-psychotic cannabinoid receptors regulate microglial cell migration. J Neurosci 23: 1398-1405.
107. Wang Z, Kai L, Day M, Ronesi J, Yin HH, Ding J, Tkatch T, Lovinger DM, Surmeier DJ. 2006. Dopaminergic control of corticostriatal long-term synaptic depression in medium spiny neurons is mediated by cholinergic interneurons. Neuron 50: 443-452.
108. Willis WD, Coggeshall RE. 2004. Sensory mechanisms of the spinal cord, Vol. 1. Primary afferent neurons and the spinal dorsal horn. New York: Kluwer Academic/Plenum Publishers.
109. Wilson RI, Nicoll RA. 2001. Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature 410: 588-592.
110. Wilson RI, Nicoll RA. 2002. Endocannabinoid signaling in the brain. Science 296: 678-682.
111. 7 receptors control 2-arachidonoylglycerol production by microglial cells. Proc Natl Acad Sci USA 101: 3214-3219.
112. Wang J, Ueda N. 2009. Biology of endocannabinoid synthetic system. Prostaglandins Other Lipid Mediat 89: 112-119.
113. Yoshida T, Fukaya M, Uchigashima M, Miura E, Kamiya H, Kano M, Watanabe M. 2006. Localization of diacylglycerol lipase-α around postsynaptic spine suggests close proximity between production site of an endocannabinoid, 2-arachidonoyl-glycerol, and presynaptic cannabinoid CB1 receptor. J Neurosci 22: 1690-1697.
114. Zhang F, Vadakkan KI, Kim SS, Wu LJ, Shang Y, Zhuo M. 2008. Selective activation of microglia in spinal cord but not higher cortical regions following nerve injury in adult mouse. Mol Pain 4: 1-16.